← Back to Search

Soft Contact Lens

Comparative Study of Two Marketed 1-day Soft Contact Lenses

N/A
Waitlist Available
Led By Thao N Yeh, OD
Research Sponsored by CooperVision International Limited (CVIL)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days and 14 days from baseline visit
Awards & highlights
No Placebo-Only Group

Summary

This study is designed to evaluate ocufilcon D lens compared to ocufilcon B lens in a 1-week crossover, daily wear regimen.

Eligible Conditions
  • Near-sightedness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days and 14 days from baseline visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days and 14 days from baseline visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lens Fit - Decentration After Insertion
Lens Fit - Decentration at One Week
Lens Fit - Post-Blink Lens Movement After Insertion
+3 more
Secondary study objectives
Overall Lens Pair Preference
Overall Preference - Comfort After Insertion
Overall Preference - Comfort Before Removal
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ocufilcon DExperimental Treatment1 Intervention
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
Group II: ocufilcon BActive Control1 Intervention
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ocufilcon B
2011
N/A
~80

Find a Location

Who is running the clinical trial?

CooperVision International Limited (CVIL)Lead Sponsor
111 Previous Clinical Trials
7,272 Total Patients Enrolled
Coopervision, Inc.Lead Sponsor
163 Previous Clinical Trials
14,125 Total Patients Enrolled
Thao N Yeh, ODPrincipal InvestigatorU.C. Berkeley, School of Optometry
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top